The Importance of Quality Patient Advocacy to Biobanks: A Lay Perspective from Independent Cancer Patients Voice (ICPV), Based in the United Kingdom

  • Maggie WilcoxEmail author
  • Margaret Grayson
  • Mairead MacKenzie
  • Hilary Stobart
  • Helen Bulbeck
  • Robert Flavel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 864)


Biobanking in the twentieth century will become of increasing importance in health research. Regulation and governance of biobanks must be open and transparent to ensure public trust and confidence and increase donation. Effective Lay Involvement all levels in biobank organisations should be standard practice helping ensure patient benefit remains the central aim and assisting the Promotion of Biobanks and Recruitment of Donors. Properly selected, educated and supported, they become valued members of the Biobank Team. This chapter is based on the work of Independent Cancer Patients’ Voice (ICPV) in the UK and recognises that the National Health Service provides a framework which is not universal and neither is the model of patient advocacy which has been developed particularly in cancer research. However, although it has not been easy to find potential members for ICPV, nor to attract funding, we have earned the respect of our professional colleagues by our commitment in giving time and developing the skills necessary to provide effective involvement. These colleagues have enthusiastically mentored and supported us and have provided venues and tutoring for Educational Events. We are sure that patient advocates in other countries would welcome the opportunity for similar involvement and hope our experiences will be of interest.


Patient advocacy Lay involvement in biobanking Donors recruitment Brain tumour tissue bank Breast cancer campaign tissue bank Patient-led consent 


  1. 1.
    Protecting Health and Scientific Research in the Data Protection Regulation (2014) Position of Non-Commercial Research Organisations and academics, 2012/0011 (COD).
  2. 2.
    Thompson A et al (2010) Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res 10:R26CrossRefGoogle Scholar
  3. 3.
    Speirs V, Morgan A (2013) Investment biobanking – increased returns on tissue samples. Nat Rev Clin Oncol 10:128–129CrossRefPubMedGoogle Scholar
  4. 4.
    Breast Cancer Campaign (2013) Always putting the patients first. Pink Sci Summer Edition: 18–19Google Scholar
  5. 5.
    Gath J, MacKenzie M, Matthews A, Morgan A, Wilcox M (2013) Patient advocate involvement shapes UK’s first national breast cancer tissue bank – Breast Cancer Campaign Tissue Bank (BCCTB). Poster presented at San Antonio breast cancer symposium, Texas, USAGoogle Scholar
  6. 6.
    Silcocks P, Steward J, Woods H (2005) Chapter 4. Brain. In: Quinn M, Wood H, Cooper N, Rowan S (eds) Cancer atlas of the United Kingdom and Ireland 1991 – 2000: studies on medical and population subjects no 68 the Office for National Statistics. Palgrave Macmillan, LondonGoogle Scholar
  7. 7.
    NICE (2006) Improving outcomes for people with brain and other CNS tumours. National Institute for Health and Clinical Excellence, London.
  8. 8.
  9. 9.
    Gaskell G, Gottweis H (2001) Biobanks need publicity. Nature 471(7337):159–160CrossRefGoogle Scholar
  10. 10.
  11. 11.
    NCRI/CCB (2014) Biobank quality and data standards.
  12. 12.
  13. 13.
    Naim F et al (2013) Patient attitudes towards undergoing additional breast biopsy for research. Breast 22:850–855CrossRefPubMedGoogle Scholar
  14. 14.
    Wolf SM et al (2012) Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 14:361–384.
  15. 15.
    Kohane IS, Mandl KD, Taylor PL, Holm IA, Nigrin DJ, Kunkel LM (2007) Medicine. Reestablishing the researcher-patient compact. Science 316:836–837CrossRefPubMedGoogle Scholar
  16. 16.
    International ethical guidelines for biomedical research involving human subjects (2002) Council for International Organizers of Medical Sciences, Geneva.
  17. 17.
    Commissioned by Wellcome Trust and MRC, conducted by Opinion Leader. Assessing public attitudes to health related findings in research 2012.
  18. 18.
    Jamal-Hanjani M et al (2014) Tracking genomic cancer evolution for precision medicine: the lung TRACERx study. PLoS Biol 12(7):e1001906, Authors include ICPV members Tom Haswell, Mairead MacKenzie and Maggie WilcoxPubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Maggie Wilcox
    • 1
    Email author
  • Margaret Grayson
    • 1
  • Mairead MacKenzie
    • 1
  • Hilary Stobart
    • 1
  • Helen Bulbeck
    • 1
  • Robert Flavel
    • 2
  1. 1.Independent Cancer Patients’ Voice (ICPV)LondonUK
  2. 2.KSS Cancer Partnership Research GroupLondonUK

Personalised recommendations